Literature DB >> 33485490

Expression of placental glucose transporter proteins in pregnancies complicated by fetal growth disorders.

Paweł Jan Stanirowski1, Michał Lipa1, Dorota Bomba-Opoń2, Mirosław Wielgoś2.   

Abstract

During pregnancy fetal growth disorders, including fetal macrosomia and fetal growth restriction (FGR) are associated with numerous maternal-fetal complications, as well as due to the adverse effect of the intrauterine environment lead to an increased morbidity in adult life. Accumulating evidence suggests that occurrence of fetal macrosomia or FGR, may be associated with alterations in the transfer of nutrients across the placenta, in particular of glucose. The placental expression and activity of specific GLUT transporters are the main regulatory factors in the process of maternal-fetal glucose exchange. This review article summarizes the results of previous studies on the expression of GLUT transporters in the placenta, concentrating on human pregnancies complicated by intrauterine fetal growth disorders. Characteristics of each transporter protein found in the placenta is presented, alterations in the location and expression of GLUT isoforms observed in individual placental compartments are described, and the factors regulating the expression of selected GLUT proteins are examined. Based on the above data, the potential function of each GLUT isoform in the maternal-fetal glucose transfer is determined. Further on, a detailed analysis of changes in the expression of glucose transporters in pregnancies complicated by fetal growth disorders is given, and significance of these modifications for the pathogenesis of fetal macrosomia and FGR is discussed. In the final part novel interventional approaches that might reduce the risk associated with abnormalities of intrauterine fetal growth through modifications of placental GLUT-mediated glucose transfer are explored.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fetal growth restriction; Fetal macrosomia; GLUT; Glucose transporter; Placenta

Mesh:

Substances:

Year:  2020        PMID: 33485490     DOI: 10.1016/bs.apcsb.2019.12.003

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  6 in total

1.  Exerkine apelin reverses obesity-associated placental dysfunction by accelerating mitochondrial biogenesis in mice.

Authors:  Song Ah Chae; Jun Seok Son; Liang Zhao; Yao Gao; Xiangdong Liu; Jeanene Marie de Avila; Mei-Jun Zhu; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-04-11       Impact factor: 5.900

Review 2.  New Insights into Adipokines in Gestational Diabetes Mellitus.

Authors:  Jorge Valencia-Ortega; Rebeca González-Reynoso; Edgar G Ramos-Martínez; Aldo Ferreira-Hermosillo; María I Peña-Cano; Enrique Morales-Ávila; Renata Saucedo
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

3.  Placental expression of glucose transporters GLUT-1, GLUT-3, GLUT-8 and GLUT-12 in pregnancies complicated by gestational and type 1 diabetes mellitus.

Authors:  Paweł Jan Stanirowski; Dariusz Szukiewicz; Agata Majewska; Mateusz Wątroba; Michał Pyzlak; Dorota Bomba-Opoń; Mirosław Wielgoś
Journal:  J Diabetes Investig       Date:  2021-10-21       Impact factor: 4.232

4.  Hyperglycemia in Pregnancy-Associated Oxidative Stress Augments Altered Placental Glucose Transporter 1 Trafficking via AMPKα/p38MAPK Signaling Cascade.

Authors:  Shuxian Wang; Jie Ning; Jing Huai; Huixia Yang
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 5.  Role of Placental Glucose Transporters in Determining Fetal Growth.

Authors:  Nikita P Joshi; Aditi R Mane; Akriti S Sahay; Deepali P Sundrani; Sadhana R Joshi; Chittaranjan S Yajnik
Journal:  Reprod Sci       Date:  2021-08-02       Impact factor: 2.924

6.  Differential Expression of Glucose Transporter Proteins GLUT-1, GLUT-3, GLUT-8 and GLUT-12 in the Placenta of Macrosomic, Small-for-Gestational-Age and Growth-Restricted Foetuses.

Authors:  Paweł Jan Stanirowski; Dariusz Szukiewicz; Agata Majewska; Mateusz Wątroba; Michał Pyzlak; Dorota Bomba-Opoń; Mirosław Wielgoś
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.